Genomic and proteomic profiles of heart disease

被引:11
作者
Prentice, H
Webster, KA
机构
[1] Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA
[2] Univ Miami, Sch Med, Vasc Biol Inst, Miami, FL USA
[3] Florida Atlantic Univ, Schmidt Biomed Res Inst, Boca Raton, FL USA
关键词
D O I
10.1016/j.tcm.2004.08.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genomics and proteomics are becoming powerful tools for profiling diseased states. The human genome is estimated to encode 30,000 to 40,000 genes, generating more than 100,000 functionally distinct proteins. Microarray data are available for multiple models of heart disease as well as for diseased and failing human hearts. Similarly, two-dimensional gel data banks of normal and diseased myocardium from multiple species are published and are available on the Internet. The combined technologies are beginning to provide new insights into the causes and pathways of cardiac dysfunction. This article reviews the novel findings that have been acquired from genomic and proteomic screens of diseased hearts in animal models and humans. (C) 2004, Elsevier Inc.
引用
收藏
页码:282 / 288
页数:7
相关论文
共 59 条
[1]   A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard [J].
Alban, A ;
David, SO ;
Bjorkesten, L ;
Andersson, C ;
Sloge, E ;
Lewis, S ;
Currie, I .
PROTEOMICS, 2003, 3 (01) :36-44
[2]   An integrated approach to proteome analysis: Identification of proteins associated with cardiac hypertrophy [J].
Arnott, D ;
O'Connell, KL ;
King, KL ;
Stults, JT .
ANALYTICAL BIOCHEMISTRY, 1998, 258 (01) :1-18
[3]   Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy [J].
Aronow, BJ ;
Toyokawa, T ;
Canning, A ;
Haghighi, K ;
Delling, U ;
Kranias, E ;
Molkentin, JD ;
Dorn, GW .
PHYSIOLOGICAL GENOMICS, 2001, 6 (01) :19-28
[4]   Cardiovascular proteomics - Evolution and potential [J].
Arrell, DK ;
Neverova, I ;
Van Eyk, JE .
CIRCULATION RESEARCH, 2001, 88 (08) :763-773
[5]   Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1 [J].
Arrell, DK ;
Neverova, I ;
Fraser, H ;
Marbán, E ;
Van Eyk, JE .
CIRCULATION RESEARCH, 2001, 89 (06) :480-487
[6]   Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray [J].
Barrans, JD ;
Allen, PD ;
Stamatiou, D ;
Dzau, VJ ;
Liew, CC .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06) :2035-2043
[7]  
BECAMEL C, 2002, BIOL P ONLINE, P94
[8]   Diffierential gene expression and genomic patient stratification following left ventricular assist device support [J].
Blaxall, BC ;
Tschannen-Moran, BM ;
Milano, CA ;
Koch, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1096-1106
[9]   Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics [J].
Brand, M ;
Ranish, JA ;
Kummer, NT ;
Hamilton, J ;
Igarashi, K ;
Francastel, C ;
Chi, TH ;
Crabtree, GR ;
Aebersold, R ;
Groudine, M .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (01) :73-80
[10]   Calpain and mitochondria in ischemia/reperfusion injury [J].
Chen, M ;
Won, DJ ;
Krajewski, S ;
Gottlieb, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) :29181-29186